(Q79208808)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14578755%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14578755%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

main subject

mesenchymal stem cell

1 reference

2

Olle Ringdén

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578755

25 March 2024

author name string

Ida Rasmusson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14578755%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Berit Sundberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14578755%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Katarina Le Blanc

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14578755%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

language of work or name

English

0 references

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14578755%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

27 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14578755

full work available at URL

25 March 2024

https://journals.lww.com/10.1097/01.TP.0000082540.43730.80

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000082540.43730.80

25 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14578755%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14578755%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14578755%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

1208-1213

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14578755%20AND%20SRC:MED&resulttype=core&format=json

Multilineage potential of adult human mesenchymal stem cells

20 December 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000082540.43730.80

Characterization of cells with osteogenic potential from human marrow

25 March 2024

2

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000082540.43730.80

Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages

25 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000082540.43730.80

Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy

25 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000082540.43730.80

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

25 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000082540.43730.80

Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex

25 March 2024

7

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000082540.43730.80

Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

25 March 2024

8

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000082540.43730.80

Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

25 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000082540.43730.80

Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect

25 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000082540.43730.80

Alloreactivity of natural killer cells in allogeneic liver transplantation

25 March 2024

12

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000082540.43730.80

Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor

25 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000082540.43730.80

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

25 March 2024

15

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000082540.43730.80

The biology of natural killer cells and implications for therapy of human disease

25 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000082540.43730.80

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

25 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000082540.43730.80

Association of natural killer cell immune recovery with a graft-versus-leukemia effect independent of graft-versus-host disease following allogeneic bone marrow transplantation

25 March 2024

18

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000082540.43730.80

Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process

25 March 2024

20

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000082540.43730.80

IL-2 activated cell-mediated immunotherapy: control of minimal residual disease in malignant disorders by allogeneic lymphocytes and IL-2

25 March 2024

21

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000082540.43730.80

IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.

25 March 2024

22

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000082540.43730.80

Donor-derived interferon gamma separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells

25 March 2024

24

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000082540.43730.80

The potential role of NK cells in the separation of graft-versus-tumor effects from graft-versus-host disease after allogeneic bone marrow transplantation

25 March 2024

26

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000082540.43730.80

Marrow stromal cells as stem cells for nonhematopoietic tissues

25 March 2024

27

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000082540.43730.80

Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering

25 March 2024

28

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000082540.43730.80

Cellular therapy: exploiting NK cell alloreactivity in transplantation

25 March 2024

29

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000082540.43730.80

25 March 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14578755%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference